Angiotensin II receptor blockers in patients with systemic right ventricular dysfunction
Latest Information Update: 04 Apr 2022
Price :
$35 *
At a glance
- Drugs Valsartan (Primary)
- Indications Right ventricular dysfunction
- Focus Therapeutic Use
- Sponsors Novartis
- 29 Aug 2012 Results presented at the ESC Congress 2012: Annual Congress of the European Society of Cardiology.
- 01 Nov 2010 Rationale and trial design were presented in an article in the American heart journal.
- 01 Jan 2010 Status changed from planning to completed as reported by ISRCTN: Current Controlled Trials.